See more : Eckoh plc (ECK.L) Income Statement Analysis – Financial Results
Complete financial analysis of Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shukra Pharmaceuticals Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Agro Tech Foods Limited (ATFL.BO) Income Statement Analysis – Financial Results
- Satin Creditcare Network Limited (SATIN.NS) Income Statement Analysis – Financial Results
- World Wrestling Entertainment, Inc. (0M1G.L) Income Statement Analysis – Financial Results
- Mitsui E&S Holdings Co., Ltd. (MIESY) Income Statement Analysis – Financial Results
- Electricité de France S.A. (EDF.VI) Income Statement Analysis – Financial Results
Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
About Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 745.73M | 588.34M | 204.86M | 111.96M | 118.46M | 56.60M | 53.44M | 51.37M | 48.25M | 25.76M | 44.31M | 51.61M | 66.33M | 98.63M | 86.34M | 73.40M | 38.19M |
| Cost of Revenue | 445.34M | 453.17M | 103.46M | 27.69M | 30.01M | 9.91M | 10.18M | 14.52M | 18.10M | 9.54M | 33.08M | 34.98M | 53.10M | 76.43M | 67.72M | 53.73M | 21.50M |
| Gross Profit | 300.39M | 135.17M | 101.40M | 84.27M | 88.45M | 46.69M | 43.26M | 36.85M | 30.16M | 16.21M | 11.23M | 16.63M | 13.23M | 22.19M | 18.62M | 19.67M | 16.69M |
| Gross Profit Ratio | 40.28% | 22.97% | 49.50% | 75.26% | 74.66% | 82.50% | 80.95% | 71.74% | 62.49% | 62.95% | 25.34% | 32.23% | 19.94% | 22.50% | 21.57% | 26.80% | 43.71% |
| Research & Development | 1.29M | 1.18M | 943.00K | 529.00K | 528.87K | 528.87K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 525.37K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.75M | 6.01M | 4.31M | 1.89M | 2.30M | 21.78M | 15.64M | 12.12M | 0.00 | 11.94M | 1.47M | 8.07M | 0.00 | 13.82M | 9.92M | 7.90M | 7.00M |
| Selling & Marketing | 21.21M | 99.00K | 90.00K | 405.00K | 23.61K | 118.43K | 10.66K | 29.47K | 0.00 | 92.64K | 1.71M | 90.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 27.95M | 6.11M | 4.40M | 2.29M | 2.32M | 21.90M | 15.65M | 12.15M | 11.50M | 12.03M | 11.96M | 8.16M | 0.00 | 13.82M | 9.92M | 7.90M | 7.00M |
| Other Expenses | 271.62M | 6.97M | 175.00K | 419.00K | 1.25K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.19M | 1.57M | 5.82M | 11.32M | 10.36M |
| Operating Expenses | 300.87M | 99.91M | 89.17M | 81.89M | 87.83M | 39.50M | 33.49M | 26.57M | 26.84M | 14.15M | 18.17M | 45.94M | -7.19M | 15.39M | 15.74M | 19.22M | 17.36M |
| Cost & Expenses | 571.70M | 553.08M | 192.63M | 109.58M | 117.84M | 49.40M | 43.67M | 41.09M | 44.94M | 23.69M | 51.25M | 80.91M | 45.92M | 91.82M | 83.46M | 72.95M | 38.86M |
| Interest Income | 5.50M | 639.00K | 314.00K | 467.00K | 84.73K | 51.33K | 305.03K | 301.61K | 191.70K | 608.26K | 39.33K | 5.83K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.76M | 2.56M | 2.81M | 130.00K | 21.00K | 6.22K | 358.31K | 58.15K | 13.71K | 0.00 | 0.00 | 261.75K | 0.00 | 0.00 | 4.26M | 665.84K | 2.08M |
| Depreciation & Amortization | 20.50M | 18.38M | 16.62M | 14.74M | 14.78M | 9.63M | 7.37M | 4.66M | 4.48M | 6.00M | 7.79M | 7.29M | 4.46M | 3.20M | 3.67M | 4.25M | 4.33M |
| EBITDA | 222.19M | 64.96M | 29.35M | 17.53M | 15.40M | 16.49M | 16.15M | 14.65M | 11.81M | -2.47M | -933.39K | 5.35M | 2.90M | 12.41M | 10.80M | 5.36M | 5.74M |
| EBITDA Ratio | 29.79% | 10.37% | 14.30% | 15.90% | 12.15% | 29.14% | 30.23% | 28.51% | 24.47% | -9.58% | -2.11% | 11.14% | 4.37% | 12.58% | 12.51% | 7.30% | 15.04% |
| Operating Income | 173.53M | 46.59M | 12.73M | 2.80M | 621.59K | 6.87M | 8.78M | 9.99M | 7.32M | -8.47M | -8.73M | -1.54M | 20.41M | 6.81M | 2.88M | 447.00K | -667.70K |
| Operating Income Ratio | 23.27% | 7.92% | 6.21% | 2.50% | 0.52% | 12.13% | 16.44% | 19.44% | 15.18% | -32.88% | -19.69% | -2.98% | 30.78% | 6.90% | 3.33% | 0.61% | -1.75% |
| Total Other Income/Expenses | 25.30M | -41.24M | -2.18M | -1.40M | -37.55M | -17.02M | -18.15M | 594.91K | -15.15M | -1.51M | -6.17M | -27.77M | 90.05K | 0.00 | 0.00 | -20.00 | 0.00 |
| Income Before Tax | 198.83M | 44.42M | 10.18M | 978.00K | 1.71M | 7.24M | 9.46M | 10.58M | 3.50M | 2.67M | -6.90M | -29.31M | 20.50M | 6.81M | 2.88M | 446.98K | -667.70K |
| Income Before Tax Ratio | 26.66% | 7.55% | 4.97% | 0.87% | 1.44% | 12.80% | 17.70% | 20.60% | 7.26% | 10.37% | -15.57% | -56.78% | 30.91% | 6.90% | 3.33% | 0.61% | -1.75% |
| Income Tax Expense | 13.46M | 352.00K | 2.67M | -902.00K | 1.35M | 2.62M | 4.20M | 5.55M | 2.31M | 1.36M | 725.35K | 0.00 | 10.97M | 0.00 | 0.00 | 96.42K | 30.00K |
| Net Income | 185.37M | 44.07M | 7.51M | 1.88M | 356.04K | 4.62M | 5.26M | 5.03M | 1.19M | 1.31M | -7.68M | -29.31M | 9.54M | 6.81M | 2.88M | 350.56K | -697.70K |
| Net Income Ratio | 24.86% | 7.49% | 3.66% | 1.68% | 0.30% | 8.16% | 9.84% | 9.79% | 2.47% | 5.08% | -17.34% | -56.78% | 14.38% | 6.90% | 3.33% | 0.48% | -1.83% |
| EPS | 4.23 | 26.21 | 4.79 | 0.25 | 0.05 | 0.74 | 0.84 | 0.80 | 0.19 | 0.21 | -1.23 | -24.76 | 1.68 | 1.20 | 0.51 | 0.06 | -0.12 |
| EPS Diluted | 4.23 | 26.21 | 4.79 | 0.25 | 0.05 | 0.74 | 0.84 | 0.80 | 0.19 | 0.21 | -1.23 | -24.76 | 1.68 | 1.20 | 0.51 | 0.06 | -0.12 |
| Weighted Avg Shares Out | 43.79M | 1.68M | 1.57M | 7.52M | 7.52M | 6.26M | 6.26M | 6.26M | 6.26M | 6.26M | 6.26M | 1.18M | 5.69M | 5.69M | 5.69M | 5.69M | 5.69M |
| Weighted Avg Shares Out (Dil) | 43.79M | 1.68M | 1.57M | 7.52M | 7.52M | 6.26M | 6.26M | 6.26M | 6.26M | 6.26M | 6.26M | 1.18M | 5.69M | 5.69M | 5.69M | 5.69M | 5.69M |
Source: https://incomestatements.info
Category: Stock Reports